Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

4,804 total articles

Booking After the 25-for-1 Split: A Tactical Long With Measured Upside

Booking After the 25-for-1 Split: A Tactical Long With Measured Upside

Booking Holdings completed a 25-for-1 forward split on 04/02/2026 that should amplify retail demand and liquidity. Fundamentals remain solid — high free cash flow, mid-20s P/E, and 2025 revenue and EPS growth — making a disciplined long the preferred trade over the next 45 trading days. Risk is real: macro travel shocks, TSA disruptions, and moment…

Buying Orla Mining After the Pullback: A Growth-Weighted Gold Bet

Buying Orla Mining After the Pullback: A Growth-Weighted Gold Bet

Orla Mining has pulled back from recent highs but fundamentals and the macro gold picture argue for a constructive stance. Recent quarterly beats, steady production, a newly instituted quarterly dividend, and exploration upside make ORLA a compelling long trade over the next 180 trading days. I lay out an entry, stop, targets, catalysts and balance…

CoreWeave Revisited: Why I'm Reiterating a Buy on CRWV

CoreWeave Revisited: Why I'm Reiterating a Buy on CRWV

<p>CoreWeave remains my preferred pure-play bet on GPU infrastructure despite clear execution and balance-sheet risks. The company sits on a multiyear demand wave from generative AI, a massive contracted backlog, and accelerating revenue guidance. That combination justifies a high-risk, high-reward long position with disciplined sizing.</p>

Microsoft's AI Reset: A Tactical Long After the Sell-Off

Microsoft's AI Reset: A Tactical Long After the Sell-Off

Microsoft's shares have been punished as investors price in a multi-year AI infrastructure build and near-term margin pressure. At $369.91, the stock trades at a materially lower multiple than its 2025 peak and offers cash-flow durability, a fortress balance sheet and exposure to cloud/AI secular growth. This trade idea lays out a mid-term (45 trad…

Buy MKKGY: Diversified Pharma & Life-Science Exposure at a Value Entry

Buy MKKGY: Diversified Pharma & Life-Science Exposure at a Value Entry

Merck KGaA (MKKGY) combines a high-quality life-science tools franchise, steady pharma royalties and specialty materials. At $25.44 the stock trades at a reasonable P/E of 18.3 and a market cap of roughly $55.3B, offering a compelling risk/reward for a long trade targeting the $31 52-week high. Technicals show constructive momentum (EMA cross, MACD…

XLG: Reasonable Entry Into Mega-Cap Leadership Despite Clear Risks

XLG: Reasonable Entry Into Mega-Cap Leadership Despite Clear Risks

XLG offers concentrated exposure to the market’s largest, fastest-growing names. Recent earnings momentum among mega-cap technology leaders supports a tactical long exposure, but concentration and macro sensitivity mean risk must be capped. Trade plan: enter $80.00, stop $72.00, target $95.00 for a mid-term trade (45 trading days).

Thales ADR: A Practical Long on Europe’s Defense and Security Rebuild

Thales ADR: A Practical Long on Europe’s Defense and Security Rebuild

THLLY (Thales unsponsored ADR) is trading above its short- and medium-term moving averages with bullish momentum indicators and recent volume that suggests renewed investor interest. With Europe increasing defense budgets, growing demand for public-safety and post-quantum cryptography solutions, and Thales’ exposure across defense, aerospace, and c…

Aimco (AIV) - Short into the Liquidation Window: A 10‑Day Play

Aimco (AIV) - Short into the Liquidation Window: A 10‑Day Play

Aimco (AIV) is in the final stages of a plan of sale and liquidation. The company has declared initial distributions and signed large asset-sale agreements, but high leverage, negative free cash flow, and a narrow window for Q2 payouts create an asymmetric near-term setup for downside. This trade targets a short-term move over the next 10 trading d…

Doubling Down on Micron: Buying the AI Memory Leader After the Pullback

Doubling Down on Micron: Buying the AI Memory Leader After the Pullback

Micron is the dominant beneficiary of the AI-driven memory cycle. Recent pullbacks over speculative threats like Google’s TurboQuant and capex worries are noise relative to the supply-demand gap for high-bandwidth memory. I am adding to my position with a clear entry, stop and target: this is a mid-term trade sized for active risk management.

RH: A Distressed Luxury Retailer Worth a Tactical Long

RH: A Distressed Luxury Retailer Worth a Tactical Long

RH (Restoration Hardware) plunged after a weak Q4 print and tariff-related headwinds. The sell-off pushes the stock to an attractive entry: P/E in the mid-20s, P/S under 1x, positive free cash flow, and a deeply oversold technical profile. High leverage is the headline risk, but a defined trade with a $100 stop and a $180 target offers attractive r…

Why United Therapeutics Remains a Strong Buy After a Second TETON Win

Why United Therapeutics Remains a Strong Buy After a Second TETON Win

United Therapeutics' second positive TETON outcome for nebulized Tyvaso plus encouraging ralinepag data clears a runway of regulatory catalysts and upside. The balance sheet and recurring revenue base justify a continued 'Strong Buy' stance. This trade idea lays out an actionable entry at the current level, a protective stop, and a target tied to r…